Nakom Mite (Carbidopa, Levodopa)

Carbidopa/Levodopa, the active ingredient in Nakom Mite, is an Antiparkinson agent presented as an oral tablet for oral use. It treats Parkinson's disease and related Parkinsonian syndromes by restoring dopamine activity in the central nervous system.

GNH USA supplies Nakom Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Carbidopa/Levodopa is used in the management of movement disorders within the Parkinsonian disease spectrum.

- Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor. - Parkinsonian syndrome: alleviates similar motor deficits caused by secondary Parkinsonism. - Levodopa‑responsive Parkinsonism: provides symptomatic relief when dopamine deficiency is the primary driver.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: gastrointestinal upset occurring early in treatment. - Orthostatic hypotension: dizziness upon standing due to vasodilation. - Insomnia: difficulty initiating or maintaining sleep. - Headache: mild to moderate cranial discomfort. - Dyskinesia: involuntary movements, especially at higher doses.

Serious or Rare Side Effects: - Hallucinations: visual or auditory disturbances requiring medical review. - Severe hypotension: marked blood pressure drop leading to syncope. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe depression or suicidal ideation: mood changes needing urgent attention. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood pressure: watch for orthostatic changes, especially in the elderly. - Assess for dyskinesia: adjust dose if involuntary movements emerge. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Use caution in cardiac disease: patients with arrhythmias may need closer observation. - Contraindicated in narrow‑angle glaucoma: may exacerbate intra‑ocular pressure. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Carbidopa/Levodopa can interact with several medication classes, altering efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (dopamine antagonists): may diminish therapeutic effect. - Alpha‑blockers: can potentiate orthostatic hypotension.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: may increase risk of serotonin syndrome. - Iron or calcium supplements: reduce levodopa absorption; separate dosing by at least 2 hours. - High‑protein meals: compete for transport across the blood‑brain barrier, potentially lowering efficacy.